Načítá se...
A case of nivolumab-induced isolated adrenocorticotropic hormone (ACTH) deficiency
One of the novel PD-1 antibodies/immune checkpoint inhibitors, nivolumab is reported to be associated with a wide range of immune-related adverse events (irAEs). We hereby report a case of isolated adrenocorticotropic hormone (ACTH) deficiency developing in a patient with squamous cell lung cancer (...
Uloženo v:
| Vydáno v: | Respir Med Case Rep |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6356048/ https://ncbi.nlm.nih.gov/pubmed/30740300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2019.01.021 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|